Form 4: Forte Biosciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Paul A. Wagner, SEE REMARKS and a Director of Forte Biosciences, Inc., reported multiple transactions in common stock on August 27, 2026.
Summary
- Tender of shares: disposed of 85,482 Common Stock on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 16,866 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 5,400 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 11,999 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 44,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 920,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 270,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 500,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 2,500 Restricted Stock Units on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 180,000 Restricted Stock Units on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 3,511 Restricted Stock Units on August 27, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Paul A. Wagner — Director, Officer (SEE REMARKS)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Tender of shares | Common Stock | 85,482 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 16,866 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 5,400 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 11,999 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 44,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 920,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 270,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 500,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Restricted Stock Units | 2,500 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Restricted Stock Units | 180,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Restricted Stock Units | 3,511 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Tender of shares (85,482 shares) |
| 2026-08-27 | Disposition to the issuer (16,866 shares) |
| 2026-08-27 | Disposition to the issuer (5,400 shares) |
| 2026-08-27 | Disposition to the issuer (11,999 shares) |
| 2026-08-27 | Disposition to the issuer (44,000 shares) |
| 2026-08-27 | Disposition to the issuer (920,000 shares) |
| 2026-08-27 | Disposition to the issuer (270,000 shares) |
| 2026-08-27 | Disposition to the issuer (500,000 shares) |
| 2026-08-27 | Disposition to the issuer (2,500 shares) |
| 2026-08-27 | Disposition to the issuer (180,000 shares) |
| 2026-08-27 | Disposition to the issuer (3,511 shares) |
Keywords
insider transaction, Form 4, FBRX, Forte Biosciences, Inc., neutral, Paul A. Wagner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.